1 clinical trial registered. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.

35 publications have been identified in PubMed for non-functional pancreatic neuroendocrine tumor. Research spans Review / Meta-Analysis (20%), Basic Science / Preclinical (20%), and Diagnostic / Biomarker (17%).

Recent Publications

• Battistella A (2026). [PMID: 41205334](https://pubmed.ncbi.nlm.nih.gov/41205334/). *Surgery*. [Clinical Trial Publication]

• Izumo W (2025). [PMID: 40055716](https://pubmed.ncbi.nlm.nih.gov/40055716/). *World J Surg Oncol*. [Epidemiology / Natural History]

• Tobias J (2025). [PMID: 40319207](https://pubmed.ncbi.nlm.nih.gov/40319207/). *Ann Surg Oncol*. [Review / Meta-Analysis]

• Partelli S (2025). [PMID: 40747911](https://pubmed.ncbi.nlm.nih.gov/40747911/). *Ann Surg*. [Diagnostic / Biomarker]

• Ji S (2025). [PMID: 40185092](https://pubmed.ncbi.nlm.nih.gov/40185092/). *Cancer Cell*. [Basic Science / Preclinical]

• Manoharan J (2025). [PMID: 40170567](https://pubmed.ncbi.nlm.nih.gov/40170567/). *J Neuroendocrinol*. [Diagnostic / Biomarker]

• Figueira ERR (2025). [PMID: 39841762](https://pubmed.ncbi.nlm.nih.gov/39841762/). *Arq Bras Cir Dig*. [Epidemiology / Natural History]

• Ren SJ (2025). [PMID: 39699960](https://pubmed.ncbi.nlm.nih.gov/39699960/). *J Surg Oncol*. [Epidemiology / Natural History]

• Alnajar A (2025). [PMID: 41008873](https://pubmed.ncbi.nlm.nih.gov/41008873/). *Cancers (Basel)*. [Epidemiology / Natural History]

• Wang F (2025). [PMID: 41224591](https://pubmed.ncbi.nlm.nih.gov/41224591/). *Pancreatology*. [Diagnostic / Biomarker]